Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Natera Inc (NTRA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates

Natera (NTRA) delivered earnings and revenue surprises of -5.77% and 3.49%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

NTRA : 25.49 (+1.07%)
Natera Reports Second Quarter 2018 Financial Results

SAN CARLOS, Calif. , Aug. 8, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ:  NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today reported financial...

NTRA : 25.49 (+1.07%)
Natera, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Natera, Inc. (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time.

NTRA : 25.49 (+1.07%)
Natera Clinical Study Validates New Biomarker for Aneuploidy and Adverse Pregnancy Outcomes

SAN CARLOS, Calif. , Aug. 7, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing, today announced new study results demonstrating that fetal fraction, as...

NTRA : 25.49 (+1.07%)
What's in Store for Penumbra (PEN) This Earnings Season?

Penumbra (PEN) deepens focus on driving innovation, ramping up production and expanding geographies.

EYE : 43.75 (-2.56%)
NTRA : 25.49 (+1.07%)
PEN : 121.55 (-2.25%)
ARDX : 4.05 (-3.57%)
Can Dental Growth Drive Henry Schein's (HSIC) Q2 Earnings?

Henry Schein (HSIC) is strongly placed to gain from the ongoing trend of digitalization in the global dental market.

EYE : 43.75 (-2.56%)
NTRA : 25.49 (+1.07%)
HSIC : 77.82 (+0.58%)
ARDX : 4.05 (-3.57%)
Study Shows Natera's Spectrum Preimplantation Genetic Testing for Aneuploidy Improves IVF Outcomes for All Women, Regardless of Maternal Age

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing, today announced the publication of a study demonstrating the value of the company's Spectrum® preimplantation genetic screening for...

NTRA : 25.49 (+1.07%)
Study Shows Natera's Spectrum Preimplantation Genetic Testing for Aneuploidy Improves IVF Outcomes for All Women, Regardless of Maternal Age

NTRA : 25.49 (+1.07%)
Natera, Inc. Announces Second Quarter 2018 Earnings Conference Call

SAN CARLOS, Calif. , Aug. 1, 2018 /PRNewswire/ -- Natera, Inc. , (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it...

NTRA : 25.49 (+1.07%)
Natera Appoints Roy Baynes to Board of Directors, Adding Deep Oncology Experience

Natera (NASDAQ: NTRA), a leader in non-invasive genetic testing, has appointed Roy Baynes, MB.BCh., M.Med., PhD, FCP, FACP, Chief Medical Officer at Merck, and Senior Vice President and Head of Global...

NTRA : 25.49 (+1.07%)
MRK : 66.72 (+0.98%)
RealNetworks Launches SAFR, a Best-In-Class Facial Recognition Platform

AI Matches Millions of Faces in Real Time

NTRA : 25.49 (+1.07%)
RNWK : 3.45 (-1.15%)
Can The Uptrend Continue for Natera (NTRA)?

Natera, Inc. (NTRA) has been on the move lately as the stock has climbed in the past four weeks

NTRA : 25.49 (+1.07%)
Natera (NTRA) Catches Eye: Stock Jumps 6.3%

Natera (NTRA) shares rose more than 6% in the last trading session, amid huge volumes.

NTRA : 25.49 (+1.07%)
BEAT : 55.20 (-3.07%)
Natera Announces Pricing of Follow-On Offering

SAN CARLOS, Calif. , July 12, 2018 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the pricing...

NTRA : 25.49 (+1.07%)
Natera Announces Pricing of Follow-On Offering

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the pricing of its underwritten public offering of 4,500,000 shares...

NTRA : 25.49 (+1.07%)
Gwilliam, Ivary, Chiosso, Cavalli & Brewer release the following: Prenatal genetic testing company accused of gender and pregnancy discrimination

A former employee has filed suit against Natera, Inc., a company that performs screening tests for pregnant women, on the grounds that she was discriminated against because of her pregnancy and gender....

NTRA : 25.49 (+1.07%)
Relatively Good Performance Detected in Shares of Vital Therapies in the Biotechnology Industry (VTL, NTRA , OPK , ALDR , INSY )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

NTRA : 25.49 (+1.07%)
OPK : 5.39 (-0.55%)
VTL : 9.30 (-1.06%)
Natera Launches Proposed Follow-On Offering

Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the launch of a proposed follow-on public offering of $75,000,000 of...

NTRA : 25.49 (+1.07%)
Natera Launches Proposed Follow-On Offering

NTRA : 25.49 (+1.07%)
Uptrend Call Working As Natera Inc Stock Rises 92.3% (NTRA)

SmarTrend identified an Uptrend for Natera Inc (NASDAQ:NTRA) on March 19th, 2018 at $10.67. In approximately 4 months, Natera Inc has returned 92.34% as of today's recent price of $20.52.

NTRA : 25.49 (+1.07%)

Van Meerten Stock Picks

5 Terrific Mid Caps
In this roller coaster market I wanted to find Mid Cap stocks that had consistent price appreciation over the last 6 month period.
EHC +0.54 , FTNT -0.51 , CAKE +0.54 , PLT +0.33 , AEO -0.09
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Agricharts Market Commentary

Today's Commentary

Corn futures ended the Monday session with most contracts 1 to 2 cents in the red. The USDA reported a private export sale of 213,372 MT to Mexico this morning, with the sale split between 2018/19 (142,248 MT) and 19/20 (71,124 MT). This morning&r...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar